Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF ISIN · CA74319B5027 US Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2020-01-21 Capital/Financing Update
Country US United States of America
Listing US PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company that develops and markets incision-free therapies for ablative interventions. The company's primary platform, TULSA-PRO®, combines real-time Magnetic Resonance (MR) imaging with robotically-driven, transurethral thermal ultrasound and closed-loop temperature feedback. This system is designed for the precise and customizable ablation of prostate tissue from the inside-out. It is used to treat various conditions, including localized prostate cancer and benign prostatic hyperplasia (BPH). The technology enables physicians to create customized treatment plans and monitor tissue temperature in real-time, aiming to maximize efficacy while preserving patient quality of life.

Recent filings

Filing Released Lang Actions
SUPPL
Capital/Financing Update Classification · 95% confidence The document is a preliminary prospectus supplement related to a short form base shelf prospectus for the offering of common shares by Profound Medical Corp. It details underwriting agreements, offering price, over-allotment options, listing information, and regulatory disclaimers. The content is typical of a capital raising or financing document, specifically a prospectus supplement for a securities offering. It is not an annual report, earnings release, or management discussion. It is not a regulatory filing or announcement of a report publication. The document is a detailed financing update related to a new share issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence score.
2020-01-21 English
FORM 6-K
Regulatory Filings Classification · 100% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It is a regulatory filing used to report material information between annual reports (20-F or 40-F). The document is short (1465 characters) and primarily serves as a cover page referencing an attached press release (Exhibit 99.1). There is no substantive financial data or detailed report content within this text. According to the rules, such filings that serve as notices or contain limited information without full financial statements or detailed analysis should be classified as Regulatory Filings (RNS).
2020-01-10 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It is a short filing (1465 characters) that primarily serves as a cover page referencing an attached press release dated January 10, 2020. There is no substantive financial data or detailed report content within this text. According to the 'Menu vs Meal' rule, such a short document that references an attached report or press release without including the full report itself should be classified as a Regulatory Filing (RNS).
2020-01-10 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data. The document length is short (1465 characters), and it primarily serves as a regulatory filing to report information to the SEC rather than a full financial report or earnings release. According to the rules, Form 6-K filings are typically classified under Regulatory Filings (RNS) unless they contain full financial reports or other specific report types. Therefore, this document fits best under Regulatory Filings (RNS).
2019-12-03 English
FORM 6-K
Regulatory Filings Classification · 100% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data. The document length is short (1467 characters), and it primarily serves as a regulatory filing to report information to the SEC. According to the rules, Form 6-K filings are considered Regulatory Filings (RNS) unless they contain full financial reports or detailed data, which this does not. Therefore, the appropriate classification is Regulatory Filings (RNS).
2019-11-25 English
FORM S-8
Capital/Financing Update Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used for registering securities to be offered under employee benefit plans such as stock option plans. It includes details about the securities to be registered, the registration fee, incorporation by reference of other filings, indemnification provisions, and undertakings related to the registration. This type of filing is a capital markets document related to securities registration and issuance, not a financial report, earnings release, or management discussion. It is not an announcement of a report but the registration statement itself. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2019-11-07 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.